The Heparin Management Test (Q57676498)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

The heparin management test: a new device for monitoring anticoagulation during coronary intervention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

G Helft

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A G Zaman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S G Worthley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Chokron

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C Le Pailleur

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

F Beygui

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C Le Feuvre

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J P Metzger

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Vacheron

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M M Samama

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

481-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

Adequate heparinization during PTCA: assessment using activated clotting times

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Antithrombotic therapy in patients undergoing coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Comparing methods of measurement: why plotting difference against standard method is misleading.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Recent changes in the management and outcome of acute closure after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

In vivo thrombus formation on a guidewire during intravascular ultrasound imaging: evidence for inadequate heparinization.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

The use of activated clotting times to monitor heparin therapy during and after interventional procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Relation between activated clotting time during angioplasty and abrupt closure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Comparison of bedside and hospital laboratory coagulation studies during and after coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900136-X

7 January 2021

10.1016/S0049-3848(99)00136-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632472%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference